The Effectiveness of Tapentadol in Perioperative Analgesia: A Prospective Comparative Study of Nasal versus Oral Preparations
Authors/Creators
- 1. Assistant Professor, Department of Anaesthesiology, KPC Medical College And Hospital, Kolkata
- 2. Final Year DNB PGT, Department of Anaesthesiology, RKMSP & VIMS, Kolkata
- 3. Associate Professor, Department of Anaesthesiology RKMSP & VIMS, Kolkata
Description
Background: Tapentadol is a relatively new analgesic. The comparison between nasal versus oral formulations was done for their various effects in the perioperative period. Setting: A study conducted in a tertiary care hospital. Materials and Methods: Sixty adults, of the American Society of Anaesthesiologists Classes I or II of either sex and age 20–60 years of age undergoing elective laparoscopic cholecystectomies done under general anaesthesia of minimum 90 minutes to less than or equal to 120 minutes duration were divided into 2 groups of 30 each by computerized random allotment (Group –N: Nasal Tapentadol, Group –T: Oral Tapentadol). Group N received two puffs of nasal Tapentadol ( Nearly 25mg per puff), 5mins before induction of anaesthesia. Group T received one oral Tapentadol tablet 100mg, 60 minutes before induction of anaesthesia. Statistics: Randomized Control trial, Proportion tests, Correlation, ANOVA, Kruskal Walis test, Regression analysis, Paired t-test, Chi-square test, F test, and, any other analysis found suitable, P-value for analytical purposes: 0.05 [95% Confidence Interval], Software for Statistical Analysis: MS-Excel/ STATA 14 were used for statistics. Results: Nasal Tapentadol group patients had significantly better analgesia 3 h postoperatively than the oral tapentadol group. Conclusions: From the Result and Analysis it was concluded that nasal Tapentadol had better analgesic efficacy and hemodynamic stability as compared to oral formulations.
Abstract (English)
Background: Tapentadol is a relatively new analgesic. The comparison between nasal versus oral formulations was done for their various effects in the perioperative period. Setting: A study conducted in a tertiary care hospital. Materials and Methods: Sixty adults, of the American Society of Anaesthesiologists Classes I or II of either sex and age 20–60 years of age undergoing elective laparoscopic cholecystectomies done under general anaesthesia of minimum 90 minutes to less than or equal to 120 minutes duration were divided into 2 groups of 30 each by computerized random allotment (Group –N: Nasal Tapentadol, Group –T: Oral Tapentadol). Group N received two puffs of nasal Tapentadol ( Nearly 25mg per puff), 5mins before induction of anaesthesia. Group T received one oral Tapentadol tablet 100mg, 60 minutes before induction of anaesthesia. Statistics: Randomized Control trial, Proportion tests, Correlation, ANOVA, Kruskal Walis test, Regression analysis, Paired t-test, Chi-square test, F test, and, any other analysis found suitable, P-value for analytical purposes: 0.05 [95% Confidence Interval], Software for Statistical Analysis: MS-Excel/ STATA 14 were used for statistics. Results: Nasal Tapentadol group patients had significantly better analgesia 3 h postoperatively than the oral tapentadol group. Conclusions: From the Result and Analysis it was concluded that nasal Tapentadol had better analgesic efficacy and hemodynamic stability as compared to oral formulations.
Files
IJTPR,Vol13,Issue3,Article28.pdf
Files
(417.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:942d577379201941d72c5c1d855c4e2c
|
417.9 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-02-28
Software
References
- 1. Apfelbaum JL, Chen C, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534-40. 2. Beauregard L, Pomp A, et al. Severity and impact of pain after daysurgery. Can J Anaesth. 1998;45:304-11. 3. 3. Dolin SJ, Cashman JN, Bland JM. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth. 2002;89:409-23. 4. McGrath B, Elgendy H, et al. Thirty percent of patients have moderate to severe pain 24 hr after ambulatory surgery: a survey of 5,703 patients. Can J Anaesth. 2004;51:886-91. 5. McHugh GA, Thoms GM et al. The management of pain following day-case surgery. Anaesthesia. 2002;57:270-5. 6. Rawal N, Hylander J, et al. Survey of postoperative analgesia following ambulatory surgery. Acta Anaesthesiol Scand. 1997;41:1017-22. 7. Carr DB, Goudas LC ,et al. Acute pain. Lancet. 1999;353:2051-8. 8. MacIntyre PE, Schug SA, et al.; on behalf of the Working Party of the Australian and New Zealand College of Anaesthetists. Acute Pain Management: Scientific Evidence, 3rd edn. Melbourne, Australia: Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine, 2010. Available at: http://www.nhmrc.gov.au/guidelines/publi cations/cp104 [Last accessed 29 Nov. 2022] 9. Perkins FM, Kehlet H et al. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 2000;9 3:1123-33. 10. Awad IT, Chung Fet al. Factors affecting recovery and discharge following ambulatory surgery. Can J Anaesth. 2006; 53:858-72. 11. Chung F, Ritchie E, et al.. Postoperative pain in ambulatory surgery. Anesth Analg. 1997;85:808-16. 12. Coley KC, Williams BA, et al. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth. 2002;14:349-53. 13. Gold BS, Kitz DS,et al. Unanticipated admission to the hospital following ambulatory surgery. JAMA. 1989; 262:3008-10. 14. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012; 116:248-73. 15. Chevlen E, Ashburn MA et al. Opioids: a review. Curr Pain Headache Rep. 2003; 7:15-23. 16. Wheeler M, Oderda GM, et al. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002;3:159- 80 17. 17. Kress HG, Kögel BY et al. Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrallyacting analgesics on the horizon? Eur J Pain. 2010;14(8):781–783. 18. Tzschentke TM, Christoph T,et al. The mu-opioid receptor Agonist/Noradrenaline reuptake inhibition (MOR–NRI) concept in analgesia: the case of tapentadol. CNS Drugs. 2014;28(4):319–329. 19. Baron R, Likar R, et al. Effectiveness of tapentadol prolonged release (PR) compared with oxycodone/naloxone PR for the management of severe chronic low back pain with a neuropathic component: a randomized, controlled, open-label, phase 3b/4 study. Pain Pract. 2016;16(5):580– 599. 20. Gálvez R, Schäfer M,et al. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study. Adv Ther. 2013;30(3):229–259. 21. Tzschentke TM, Christoph T, et al. (-)- (1R,2R)-3- (3-dimethylamino-1-ethyl-2- methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther. 2007; 323(1):265–276. 22. Lagas JS, Wagenaar JF,et al. Lethal morphine intoxication in a patient with a sickle cell crisis and renal impairment: case report and a review of the literature. Hum Exp Toxicol. 2011;30(9):1399–1403. 23. Buynak R, Shapiro DY, et al. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placeboand active-controlled Phase III study. Expert Opin Pharmacother. 2010;11(11):1787–1804. 24. Wild JE, Grond S, et al. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain. Pain Pract. 2010;10(5):416–427. 25. Lerner D, Chang H, et al. Imputing at-work productivity loss using results of a randomized controlled trial comparing tapentadol extended release and oxycodone controlled release for osteoarthritis pain. J Occup Environ Med. 2012;54(8):933–938. 26. Daniels S, Casson E, et al. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin. 2009;25(6):1551–1561. 27. Sarika, Wadhwa R, et al. Research article a randomised double blind study comparing preemptive analgesic efficacy of oral acetaminophen, diclofenac and combination of acetaminophen and diclofenac in modified radical mastectomy surgery. Int J Recent Scientific Res. 2015;6(10):6702-6706. 28. Ayan M, Taş U, et al. Comparing efficiencies of diclofenac sodium and paracetamol in patients with primary dysmenorrhea pain by using Visual Analog Scale. Agri. 2013;25(2):78-82.